Lucid Motors is one of the hottest electric vehicle (EV) start-ups that is coming to the public markets this year, recently announcing that it will be merging with Churchill Capital IV (NYSE:CCIV), a special-purpose acquisition company (SPAC). Electric pickup truck and SUV maker Rivian is reportedly planning to go public in 2021, although it is said to be opting for a traditional IPO instead of the SPAC route. EV stocks have been booming in recent months on hopes that the Biden administration will pursue policies to promote EV adoption.

As the most prominent pure-play EV maker, there will always be inevitable comparisons to Tesla (NASDAQ:TSLA). That's especially true for Lucid, since the company was founded and is currently managed by former Tesla executives, and the new entrant is also pursuing many of the same go-to-market strategies. Lucid CEO Peter Rawlinson has framed competition in the EV market as a technology race. Here are three major technology advantages that Lucid claims it will have over Tesla.

More in category

Uber expands higher-margin U.S. transit software business with three new agencies
April 14, 2021Reuters
Uber expands higher-margin U.S. transit software business with three new agencies
J&J investor calls on shareholders to reject CEO Gorsky's pay
April 14, 2021Reuters
J&J investor calls on shareholders to reject CEO Gorsky's pay
Goldman Sachs profit soars on global deals frenzy, trading boom
April 14, 2021Reuters
Goldman Sachs profit soars on global deals frenzy, trading boom
JPMorgan profits on capital markets in a cash-flush economy
April 14, 2021Reuters
JPMorgan profits on capital markets in a cash-flush economy
Kohl's strikes deal with activists, to name three new directors to its board
April 14, 2021CNBC
Kohl's strikes deal with activists, to name three new directors to its board
Moderna hopes to have Covid booster for its vaccine ready by the fall, CEO says
April 14, 2021CNBC
Moderna hopes to have Covid booster for its vaccine ready by the fall, CEO says
Bernie Madoff, mastermind of the nation's biggest investment fraud, dies at 82
April 14, 2021CNBC
Bernie Madoff, mastermind of the nation's biggest investment fraud, dies at 82
Energy firm plans hydrogen project that will use UK's largest electrolyzer
April 14, 2021CNBC
Energy firm plans hydrogen project that will use UK's largest electrolyzer
EU moves up delivery of 50 million BioNTech-Pfizer vaccine doses
April 14, 2021MarketWatch
EU moves up delivery of 50 million BioNTech-Pfizer vaccine doses
Goldman Sachs stock rises after record profit and revenue beat by wide margins
April 14, 2021MarketWatch
Goldman Sachs stock rises after record profit and revenue beat by wide margins
Hundreds of companies and executives sign statement opposing voting restrictions in two-page ad in New York Times
April 14, 2021MarketWatch
Hundreds of companies and executives sign statement opposing voting restrictions in two-page ad in New York Times
U.S. stocks edge higher as investors parse Goldman Sachs, JPMorgan earnings
April 14, 2021MarketWatch
U.S. stocks edge higher as investors parse Goldman Sachs, JPMorgan earnings
J.P. Morgan net profit soars fivefold to $14.3 billion and revenue tops expectations, but stock slips
April 14, 2021MarketWatch
J.P. Morgan net profit soars fivefold to $14.3 billion and revenue tops expectations, but stock slips
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
April 14, 2021MarketWatch
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
This robot-run fund with a history of predicting Tesla price moves has just made these stock picks
April 14, 2021MarketWatch
This robot-run fund with a history of predicting Tesla price moves has just made these stock picks
Earnings season is starting. Why you might want to take a look at the weather, too.
April 14, 2021MarketWatch
Earnings season is starting. Why you might want to take a look at the weather, too.
Johnson & Johnson saga reveals critical strengths in the U.S. COVID-19 mass-vaccination strategy — and its weaknesses
April 13, 2021MarketWatch
Johnson & Johnson saga reveals critical strengths in the U.S. COVID-19 mass-vaccination strategy — and its weaknesses
The 24 most-hated stocks in the S&P 500, and why you should love them
April 13, 2021MarketWatch
The 24 most-hated stocks in the S&P 500, and why you should love them
Opinion: The madness of stock picking
April 13, 2021MarketWatch
Opinion: The madness of stock picking
Opinion: GameStop’s stock price is down 50% from the highs — and it’s still crazy
April 13, 2021MarketWatch
Opinion: GameStop’s stock price is down 50% from the highs — and it’s still crazy
Rare blood clots tied to J&J’s COVID-19 shot are similar to issues with AstraZeneca’s vaccine, FDA official says
April 13, 2021MarketWatch
Rare blood clots tied to J&J’s COVID-19 shot are similar to issues with AstraZeneca’s vaccine, FDA official says